Intended for healthcare professionals

  1. Research
  2. Adverse...
  3. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.
Research Article

Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.

British Medical Journal 1988; 297 doi: https://doi.org/10.1136/bmj.297.6659.1304 (Published 19 November 1988) Cite this as: British Medical Journal 1988;297:1304

Related articles

See more

Cited by...

  • Outcomes of outborn extremely preterm neonates admitted to a NICU with respiratory distress
  • Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring
  • Midwife or doctor local opinion leader to implement a national guideline in babies on postnatal wards (DesIGN): protocol of a cluster-randomised, blinded, controlled trial
  • Impact of hypoglycaemia on neurodevelopmental outcomes in hypoxic ischaemic encephalopathy: a retrospective cohort study
  • Neonatal Hypoglycemia
  • Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial
  • How to use a controlled fast to investigate hypoglycaemia
  • Developmental Outcomes of Preterm Infants With Neonatal Hypoglycemia
  • Modern Management of Preterm Infants Prevents Adverse Developmental Outcomes From Hypoglycemia
  • Clinically stable very low birthweight infants are at risk for recurrent tissue glucose fluctuations even after fully established enteral nutrition
  • Brain Injury Patterns in Hypoglycemia in Neonatal Encephalopathy
  • 15-Year Follow-Up of Recurrent "Hypoglycemia" in Preterm Infants
  • Tight Glycemic Control With Insulin in Hyperglycemic Preterm Babies: A Randomized Controlled Trial
  • Diabetes in pregnancy: health risks and management
  • Recognizing Hypoglycemia in Children Through Automated Adverse-Event Detection
  • Carbon Dioxide and Glucose Affect Electrocortical Background in Extremely Preterm Infants
  • A hypoglycaemic baby on the postnatal ward
  • Can Association Between Preterm Birth and Autism be Explained by Maternal or Neonatal Morbidity?
  • Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation
  • Strict Glycemic Targets Need Not Be So Strict: A More Permissive Glycemic Range for Critically Ill Children
  • Occipital Lobe Injury and Cortical Visual Outcomes After Neonatal Hypoglycemia
  • Patterns of Cerebral Injury and Neurodevelopmental Outcomes After Symptomatic Neonatal Hypoglycemia
  • Lipolysis and Insulin Sensitivity at Birth in Infants Who Are Large for Gestational Age
  • Neurodevelopment After Neonatal Hypoglycemia: A Systematic Review and Design of an Optimal Future Study
  • Research in Neonatology for the 21st Century: Executive Summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics Workshop. Part I: Academic Issues
  • Neonatal Hypoglycemia: Fifty Years Later, The Questions Remain the Same
  • Neurologic Outcomes of 90 Neonates and Infants With Persistent Hyperinsulinemic Hypoglycemia
  • Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate
  • Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age
  • Therapeutic insulin and hepatic glucose-6-phosphatase activity in preterm infants
  • Controversies Regarding Definition of Neonatal Hypoglycemia: Suggested Operational Thresholds
  • Neonatal hypoglycaemia in Nepal 1. Prevalence and risk factors
  • Workshop Summary: Nutrition of the Extremely Low Birth Weight Infant
  • Symptomatic Hypoglycemia in Otherwise Healthy, Breastfed Term Newborns
Back to top